Company page

Santhera Pharmaceuticals Holding Ag

Santhera Pharmaceuticals Holding AG is a public company listed on the Swiss market under the ticker SANN. The company has a market capitalization of approximately 268 million Swiss francs. Santhera focuses on developing innovative therapies for rare diseases, particularly in the field of neuromuscular disorders.

SANN:SIXUpdated August 21, 2026
Santhera Pharmaceuticals Holding Ag logo
Ticker
SANN:SIX
Asset type
Stock
Market cap
$306.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
SIX
Currency
CHF